Clinical trial
Evaluation of the Effects of Different Interventions on Glycemic Control in…
NCT00147836 · Sun Yat-sen University, Other · Completed
Key facts
| NCT number | NCT00147836 |
|---|---|
| Title | Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients |
| Official title | Evaluation of the Effects of Oral Anti-Hyperglycemic Agents, Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion on Glycemic Control, B-Cell Function and the Remission Rate in Newly-Diagnosed Type 2 Diabetic Patients |
| Lead sponsor | Sun Yat-sen University, Other |
| Collaborators | Ministry of Education, China Guangdong Science and Technology Bureau, China Hoffmann-La Roche Industry Novo Nordisk A/S |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Device, Drug, Other |
| Interventions | Human Insulin (Novolin-R, Novo Nordisk), H-Tron Plus V100, Disetronic Medical System, Burgdorf, Switzerland, Pre-meal, Novolin-R, Human Insulin NPH (Novolin-N, Gliclazide (Diamicron and 2 more |
| Enrollment | 436 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 1, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: